You are here : Home > News Archive > CARBOGEN AMCIS AG Exhibits at th...
CARBOGEN AMCIS AG Exhibits at the 4th Biotech Outsourcing Strategies cmc 2011 (BOS cmc

Meet us at BOS cmc (16 June 2011): Booth B

4 May 2011

BUBENDORF, Switzerland (May 4, 2011) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is exhibiting at the 4th Biotech Outsourcing Strategies cmc (BOS cmc), on June 16th at the stand # B, in the Søhuset Conference Centre, in Hørsholm (Copenhagen), Denmark. The outsourcing partnering event is focused on chemistry, manufacturing and controls (CMC) services for small molecules and biopharmaceuticals and has been organized by Bio2Business Ltd.

 

CARBOGEN AMCIS will present its integrated CMC services for the support of API supply such as PR&D, scale-up, manufacturing and integrated analytical services. With three sites in Switzerland equipped with cGLP labs, FDA inspected cGMP manufacturing areas and high potency suits, CARBOGEN AMCIS positions itself as the ideal partner for the custom manufacturing and the commercialization of small molecules, drug conjugates and highly potent APIs.

 

During the BOS cmc conference program on small molecules, Alexander Strätz, PhD, CARBOGEN AMCIS’ sales manager, will give a presentation entitled: “CARBOGEN AMCIS – your gateway to commercialization” on Thursday, June 16th at 11.40-11.50 am.

 

If you would like to arrange to speak with one of our representatives at the meeting please contact:

Dr. Alexander Strätz, alexander.straetz@carbogen-amcis.com Mob: +49 (0)162 4262435

 

###

 

CARBOGEN AMCIS AG is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.

 

Dishman Group (www.dishmangroup.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. Dishman Group improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe, China and India.

 

Bio2Business Ltd (www.bio2bevents.com) is a life science consultancy based in London. Formed in August 2004 Bio2Business facilitates partnering in the UK biotech sector through targeted business development activities. Bio2Business Event Management division is dedicated to building the Biotech Outsourcing Strategies (BOS) series of events. BOS events are primarily business 2 business partnering events to bring together biotech drug development executives and high quality service providers in small molecule and biopharmaceutical drug development.

News
21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

11 August 2016
Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS

14 July 2016
CARBOGEN AMCIS Sites at Aarau and Neuland in Switzerland Successfully Pass FDA Inspection


Events
World ADC San Diego

CPhI WW